Cancer Analysis & Statistics
New
Regionally, according to BIS Research estimates about the target patient pool of extensive stage small cell lung cancer, the U.S. and the U.K. occupy the top position among the seven major markets, fo…
New
The Global Oncology Partnering 2015-2022: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds lea…
New
Computer Aided Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others), By Appl…
New
Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication …
New
Major players in the hospital asset tracking and inventory management systems market are ZIH Corp, Ascom, GE Healthcare (General Electric Company), CenTrak (Halma plc), Honeywell International Inc., A…
New
2022-2027 Asia-Pacific Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- An 18-Country Database and Analys…
New
2022-2027 Latin America Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- A 22-Country Database and Analys…
New
2022-2027 Middle East Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- An 11-Country Database and Analysi…
New
2022-2027 North America Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--US, Canada, Mexico--2022 Supplier…
New
2022-2027 Global Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--US, Europe, Japan--2022 Supplier Shares …
New
2022-2027 Europe Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--France, Germany, Italy, Spain, UK--2022 …
New
The embolotherapy market in North America is expected to grow from US$ 1,354.02 million in 2022 to US$ 2,245.73 million by 2028. It is estimated to grow at a CAGR of 8.8% from 2022 to 2028. Rising Pr…
New
The embolotherapy market in South & Central America is expected to grow from US$ 230.83 million in 2022 to US$ 339.16 million by 2028. It is estimated to grow at a CAGR of 6.6% from 2022 to 2028. Ris…
New
The embolotherapy market in Asia Pacific is expected to grow from US$ 781.80 million in 2022 to US$ 1,272.58 million by 2028. It is estimated to grow at a CAGR of 8.5% from 2022 to 2028. Growing Use …
New
The embolotherapy market in Europe is expected to grow from US$ 1,050.81 million in 2022 to US$ 1,638.92 million by 2028. It is estimated to grow at a CAGR of 7.7% from 2022 to 2028. Rising Prevalenc…
New
The embolotherapy market in the Middle East & Africa is expected to grow from US$ 183.66 million in 2022 to US$ 261.89 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2022 to 2028. Wi…
New
Global Lung Cancer Therapeutics Market 2023-2027 The analyst has been monitoring the lung cancer therapeutics market and it is poised to grow by $10204.33 mn during 2023-2027, accelerating at a CAGR o…
New
The APAC asparaginase market is expected to grow from US$ 132.43 million in 2022 to US$ 341.39 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2022 to 2028. Increase in Pharmaceutica…
New
The Europe asparaginase market is expected to grow from US$ 189.17 million in 2022 to US$ 451.68 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2022 to 2028. Use of Asparaginase in …
New
The MEA asparaginase market is expected to grow from US$ 22.60 million in 2022 to US$ 48.37 million by 2028; it is estimated to grow at a CAGR of 13.5% from 2022 to 2028. New Product Launches and App…
New
The North America asparaginase market is expected to grow from US$ 267.71 million in 2022 to US$ 660.94 million by 2028; it is estimated to grow at a CAGR of 16.3% from 2022 to 2028. Rising Applicati…
New
The global cancer/tumor profiling market is projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period. Growth in this market is majorly dr…
New
Forecasts by Indication (Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukaemia (ALL), Follicular Lymphoma, Multiple Myeloma (MM), Other), by Type (Abecma, Yescarta, Kymriah, Tecartus, O…
New
Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital He…
New
Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Drug Class (Alkylating Agents, Mitotic Inhibitors, Antirheumatics, Antipsoriatics, …
New
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Kaposi Sarcoma - D…
New
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Heal…
New
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guid…
New
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthc…
New
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin …